Gladeo – Trademark Portfolio

Entity Type: 03

Gladeo holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GLADEO. The owner is based in Santa Monica, CA.

3110 Main Street, Building C

Santa Monica, CA 90405

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GLADEO
GLADEO
Registered 2018

Trademark Classifications

Gladeo's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Gladeo have?

Gladeo has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Gladeo file in?

Gladeo files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are Gladeo's most well-known trademarks?

Gladeo's registered trademark portfolio includes well-known marks such as GLADEO. These are among 1 currently registered trademark in the portfolio.

What is Gladeo's trademark registration success rate?

Gladeo has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.